Health care costs are on the rise in Australia. Rational decisions using cost-effectiveness analyses are necessary to prioritise health interventions for the allocation of limited resources. Immunisation is an important component of preventive health care intervention and its cost-effectiveness analyses are useful in prioritising the choices. This book describes economic evaluation of two immunisation interventions in Australia: influenza and hepatitis B. We have analysed cost-effectiveness of reducing universal influenza vaccination age threshold to 50 from the current 65 using a decision tree model and cost-effectiveness of various hepatitis B infant vaccination strategies using a micro-simulation model. Here we describe the strength of the evidence to reduce universal influenza vaccination age threshold. Our results also suggest that the current hepatitis B vaccination strategy in Australia is an expensive one, but yields maximum health gain in general population. Is that the best choice? How good is Australian hepatitis B immunization strategy for indigenous population? Do we have alternative cost-effective choices? This book tries to explore all these questions.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Dr.Vittal Mogasale, M.B.B.S., M.P.H., Ph.D., is a Physician, Public Health Professional and Health Economist who has worked for the control of communicable diseases over a decade in India. Now he works with International Vaccine Institute, Seoul to facilitate the introduction of new and improved vaccines in developing countries.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Health care costs are on the rise in Australia. Rational decisions using cost-effectiveness analyses are necessary to prioritise health interventions for the allocation of limited resources. Immunisation is an important component of preventive health care intervention and its cost-effectiveness analyses are useful in prioritising the choices. This book describes economic evaluation of two immunisation interventions in Australia: influenza and hepatitis B. We have analysed cost-effectiveness of reducing universal influenza vaccination age threshold to 50 from the current 65 using a decision tree model and cost-effectiveness of various hepatitis B infant vaccination strategies using a micro-simulation model. Here we describe the strength of the evidence to reduce universal influenza vaccination age threshold. Our results also suggest that the current hepatitis B vaccination strategy in Australia is an expensive one, but yields maximum health gain in general population. Is that the best choice How good is Australian hepatitis B immunization strategy for indigenous population Do we have alternative cost-effective choices This book tries to explore all these questions. 128 pp. Englisch. Bestandsnummer des Verkäufers 9783846504048
Anzahl: 2 verfügbar
Anbieter: moluna, Greven, Deutschland
Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Mogasale VittalDr.Vittal Mogasale, M.B.B.S., M.P.H., Ph.D., is a Physician, Public Health Professional and Health Economist who has worked for the control of communicable diseases over a decade in India. Now he works with Internatio. Bestandsnummer des Verkäufers 5495167
Anzahl: Mehr als 20 verfügbar
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Health care costs are on the rise in Australia. Rational decisions using cost-effectiveness analyses are necessary to prioritise health interventions for the allocation of limited resources. Immunisation is an important component of preventive health care intervention and its cost-effectiveness analyses are useful in prioritising the choices. This book describes economic evaluation of two immunisation interventions in Australia: influenza and hepatitis B. We have analysed cost-effectiveness of reducing universal influenza vaccination age threshold to 50 from the current 65 using a decision tree model and cost-effectiveness of various hepatitis B infant vaccination strategies using a micro-simulation model. Here we describe the strength of the evidence to reduce universal influenza vaccination age threshold. Our results also suggest that the current hepatitis B vaccination strategy in Australia is an expensive one, but yields maximum health gain in general population. Is that the best choice How good is Australian hepatitis B immunization strategy for indigenous population Do we have alternative cost-effective choices This book tries to explore all these questions.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 128 pp. Englisch. Bestandsnummer des Verkäufers 9783846504048
Anzahl: 1 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Health care costs are on the rise in Australia. Rational decisions using cost-effectiveness analyses are necessary to prioritise health interventions for the allocation of limited resources. Immunisation is an important component of preventive health care intervention and its cost-effectiveness analyses are useful in prioritising the choices. This book describes economic evaluation of two immunisation interventions in Australia: influenza and hepatitis B. We have analysed cost-effectiveness of reducing universal influenza vaccination age threshold to 50 from the current 65 using a decision tree model and cost-effectiveness of various hepatitis B infant vaccination strategies using a micro-simulation model. Here we describe the strength of the evidence to reduce universal influenza vaccination age threshold. Our results also suggest that the current hepatitis B vaccination strategy in Australia is an expensive one, but yields maximum health gain in general population. Is that the best choice How good is Australian hepatitis B immunization strategy for indigenous population Do we have alternative cost-effective choices This book tries to explore all these questions. Bestandsnummer des Verkäufers 9783846504048
Anzahl: 1 verfügbar
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Cost-effectiveness of Selected Immunisation Programs in Australia | Economic evaluation of influenza and hepatitis B immunization programs in Australia | Vittal Mogasale | Taschenbuch | 128 S. | Englisch | 2011 | LAP LAMBERT Academic Publishing | EAN 9783846504048 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu. Bestandsnummer des Verkäufers 106763674
Anzahl: 5 verfügbar